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Sphingosine 1- phosphate is a bioactive
sphingolipid that regulates cell growth
and suppresses programmed cell death.
The bio- synthesis of sphingosine 1phosphate is catalyzed by sphingosine
kinase (SK) but the mechanism by which
the subcellular localization and activity of
SK is regulated in response to various
stimuli is not fully understood. To
elucidate the origin and structural
determinant of the specific subcellular
localization of SK, we performed
biophysical and cell studies of human
SK1 (hSK1) and selected mutants.
*

This work was supported by National Institutes of
Health Grants GM52598, GM53987, GM68849 (to
W. C.), and GM062887 (to L. M. O.). The costs of
publication of this article were defrayed in part by the
payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance
with 18 U. S. C. Section 1734 solely to indicate this
fact.
1
Both authors contributed equally to this work.
2
To whom correspondence should be addressed: M/C
111, 845 West Taylor St., Chicago, IL 60607-7061.
Tel.: 312-996-4883; Fax: 312-996-2183; E-mail:
wcho@uic.edu.
3
The abbreviations used are S1P, sphingosine 1phosphate; EGFP, enhanced green fluorescent
protein; hSK1; human sphingosine kinase 1; PA,
phosphatidic acid; PMA, phorbol 12- myristate 13acetate; POPC, 1- palmitoyl- 2- oleoyl- sn- glycerol3- phosphocholine; POPE, 1- palmitoyl- 2- oleoylsn- glycero- 3- phosphoethanolamine; POPG, 1-

palmitoyl- 2- oleoyl- sn- glycero- 3phosphoglycerol; POPI, 1- palmitoyl- 2- oleoyl- snglycero- 3- phosphoinositol; POPS, 1- palmitoyl- 2oleoyl- sn- glycero- 3- phosphoserine; PKC, protein
kinase C; PS, phosphatidylserine; SK, sphingosine
kinase; SPH, sphingosine; SPR, surface plasmon
resonance; HEK, human embryonic kidney; POPA,
1- Palmitoyl- 2- oleoyl- sn- glycerol- 3- phosphatidic
acid.

In vitro measurements showed that hSK1
selectively bound phosphatidylserine over
other anionic phospholipids and strongly
preferred the plasma membranemimicking membrane to other cellular
membrane mimetics. Mutational analysis
indicates that conserved Thr54 and Asn89
in the putative membrane- binding
surface are essential for lipid selectivity
and membrane targeting both in vitro and
in the cell. Also, phosphorylation of Ser225
enhances the membrane affinity and
plasma membrane selectivity of hSK1,
presumably by modulating the
interaction of Thr54 and Asn89 with the
membrane. Collectively, these studies
suggest that the specific plasma
membrane localization and the activation
of SK1 is mediated largely by specific
lipid- protein interactions.

Sphingosine 1- phosphate (S1P)3 is a
recently identified bioactive lipid that can
act both extracellularly and intracellularly as
a first and a second messenger, respectively
(1). It has been shown that S1P is excreted
into serum from platelets and binds
members of the endothelial differentiation
gene receptor family (S1P1-5) to activate
cellular processes such as differentiation,
migration, and mitogenesis (2).
Intracellularly, S1P has been implicated in
signaling cascades that lead to cytoskeletal
changes, motility, release of intracellular
Ca2+ stores, and protection from apoptosis
(3-6). S1P is formed from sphingosine
(SPH) by sphingosine kinase (SK) and is
degraded by S1P lyase and S1P
phosphatases (1). In the resting state of cells,
the balance between S1P formation and
degradation maintains the low basal levels
of S1P. However, cellular S1P levels have
been shown to increase rapidly and
transiently by agonists that activate SK, such
as tumor necrosis factor- α (7, 8), plateletderived growth factor (9), nerve growth
factor (10, 11), muscarinic acetylcholine
agonists (12), or phorbol esters (13, 14).
Two types of mammalian SKs (SK1
and SK2) have been characterized so far (15,
16), both of which are primarily cytosolic
proteins. A recent study suggested that a
phorbol ester, phorbol 12- myristate 13acetate (PMA), induces the protein kinase C
(PKC)- mediated phosphorylation and the
localization of SK1 to the plasma membrane
in human embryonic kidney (HEK) 293
cells (17), which leads to enhanced release
of S1P to the media. Subsequently, it was
reported that PMA and tumor necrosis
factor- α induced the phosphorylation of

Ser225 of SK1 through the activation of
mitogen- activated protein kinase,
extracellular signal- regulated kinase ½,
which resulted in plasma membrane
localization and activation of SK1 (18). It
has been also reported that the subcellular
localization of SK1 is medicated by
interactions with putative adapter proteins
(19, 20). However, it is still unknown how
SK is specifically targeted to the plasma
membrane and how phosphorylation triggers
the subcellular localization of SK. To
elucidate the origin and structural
determinants of its specific subcellular
localization of SK, we performed
biophysical and cell studies of human SK1
(hSK1) and selected mutants. The results
from this study provide new insight into
how the membrane recruitment of this
important protein is regulated in the cell.
EXPERIMENTAL PROCEDURES
Materials- 1-Palmitoyl- 2- oleoylsn- glycerol- 3- phosphatidic acid (POPA),
1- palmitoyl- 2- oleoyl- sn- glycerol- 3phosphocholine (POPC), 1- palmitoyl- 2oleoyl- sn- glycero- 3- phosphoethanolamine
(POPE), 1- palmitoyl- 2- oleoyl- snglycero- 3- phosphoglycerol (POPG), 1palmitoyl- 2- oleoyl- sn- glycero- 3phosphoinositol (POPI), 1- palmitoyl- 2oleoyl- sn- glycero- 3- phosphoserine
(POPS), and D-erythro-SPH (C20)were
purchased from Avanti Polar Lipids, Inc.
(Alabaster, AL) and used without further
purification. PMA was from Sigma. Silica
thin layer chromatography G-60 plate was
from Merck.
Protein Expression and PurificationAll SK1 proteins were expressed in

baculovirus- infected Tn5 cells as soluble
proteins with a C- terminal His6 tag and
purified from the cell extracts using a Ni2+nitrilotriacetic acid- agarose column
(Qiagen) according to the manufacturer’s
protocol. All proteins were >90% pure
electrophoretically. Protein concentration
was determined by bicinchoninic acid
method (Pierce).
Surface Plasmon Resonance
Analysis- The kinetic SPR measurements
ere performed at
C in 20 mм HEPES,
pH 7.4, containing 0.16 M KCl using a
lipid- coated L1 chip in the BIACORE X
system as described previously (21). Cell
membrane- mimicking vesicles were
prepared as described (22). The control
sensor surface was coated with 100% POPC
vesicles for which all hSK1 proteins have
extremely low affinity, and the active sensor
surface was coated with vesicles indicated in
TABLES ONE and TWO. All data were
analyzed using BIAevaluation 3.0 software
(Biacore) to determine ka and kd, and
equilibrium dissociation constant (Kd) was
then calculated using an equation, Kd= kd/ka
assuming 1:1 binding: i.e. protein + (protein
binding site on vesicle)
(complex) (21).
Monolayer Measurements- Surface
pressure (π) of solution in a circular Teflon
trough (4 cm diameter x 1 cm deep) was
measured using a Wilhelmy plate attached to
a computer- controlled Cahn electrobalance
as described previously (23). Five to ten μl
of phospholipid solution in ethanol/ hexane
(1:9 (v/v)) was spread onto 10 ml of
subphase (20 mм HEPES, pH 7.4,
containing 0.16 M KCL, and either 0.1 mм
EGTA or 0.1 mм CaCl2) to form a

monolayer with a given initial surface
pressure (πo). Once the surface pressure
reading of monolayer had been stabilized
(after about 5 min), the protein solution
(typically 40 μl) as injected into the
subphase through a small hole drilled at an
angle through the wall of the trough and the
change in surface pressure (Δπ) as
measured as a function of time. Typically,
the Δπ value reached a maximum after 0
min. The maximal Δπ value at a given π
depended on the protein concentration and
reached a saturation value (i.e. [hSK1] ≥ 1.0
μg/ ml). Protein concentrations in the
subphase were therefore maintained above
such values to ensure that the observed Δπ
represented a maximal value. The critical
surface pressure (πc) was determined by
extrapolating the Δπ versus πo plot to the xaxis (24).
SK1 Activity Assay- In vitro hSK1
activity was measured in the absence or
presence of lipid vesicles according to the
procedure by Olivera and Spiegel (25). For
the assays without lipid vesicles, the
recombinant hSK1 was added to 20 mм Tris
buffer (pH 7.4) containing 0.16 м KCl, 5 μм
ᴅ- erythro- SPH- bovine serum albumin
adduct (99.7:0. in mole ratio), 1 mм [γ32
P]ATP (Amersham Biosciences; 1 μCi),
and 500 μм MgCl2. After the reaction
mixture as incu ated at
C for 0 min,
lipids were extracted with 2.5 volumes of
chloroform/ butanol/ HCl (50:50:1, v/v/v/),
and the organic layer was dried under a
gentle stream of nitrogen. SPH and S1P
were separated by thin layer
chromatography using butanol/ methanol/
acetic acid/ water (80:20:12:20, v/v/v/v) as
eluent. Bands corresponding to S1P were

scraped and the radioactivity measured
using a scintillation counter. Activity assays
in the presence of lipid vesicles were
performed in 0 mм Tris uffer (pH 7.4)
containing 0.16 м KCl, 5 μм ᴅ- erythroSPH incorporated into phospholipid vesicles
of various compositions (5 μм total
concentration), 1 mм [γ- 32P]ATP
(Amersham Biosciences; 1 μCi), and 500 μм
MgCl2. For cellular SK1 activity assays,
transfected HEK293 cells were treated with
μм PMA for the indicated times, and 10
min before the end of the time point, cells
ere pulsed ith 00 nм ᴅ- [erythro3
H]SPH (American Radiolabeled Co.; 1.0
μCi). The secreted S1P as extracted and
counted as described above.
Cell Culture, Transfection and
Confocal Microscopy- Wild type hSK1 and
its mutants were su cloned in- frame ith a
C- terminal enhanced green fluorescent
protein (
P) into the p
vector. Sta le
H K 9 cells expressing ecdysone receptor
( nvitrogen) ere gro n in ul ecco’s
modified agle’s medium containing 10
fetal ovine serum at 7 C with 5% CO2 and
98% humidity. The cell transfection and the
protein expression were performed as
described elsewhere (22). Confocal
imagining was performed using a four
channel Zeiss LSM 510 laser scanning
microscope. EGFP was excited using the
488- nm line of an argon/ krypton laser. A
505- nm line pass filter and a x 63, 1.2
numerical aperture waster immersion
objective were used for all experiments.
Immediately before imagining, induction
media was removed as the cells were
ashed t ice ith 1 mм H P S (pH 7.4),
containing .5 mм MgCl2, 140 mм aCl, 5

mм KCL, and 6 mм sucrose. The cells ere
then overlaid with the same buffer and
imaged. Translocation experiemtns were
monitored by scanning every 30 s following
treatment of the cells with 2 μм PMA. The
time lapse changes in EGFP intensity ratio
at the plasma membrane (= plasma
membrane/ [plasma membrane +
cytoplasm]) were determined as described
previously (22).
Determination of
225
Ser Phosphorylation by Mass
Spectrometry- The hSK1 bands were
excised from the Coomassie Brilliant Bluestained sodium dodecyl sulfatepolyacrylamide gel. The excised bands were
washed three times with acetonitrile/ H2O
(1:1, v/v) for 10 min and dehydrated with
acetonitrile. Then, the bands were finally
washed with 1:1 (v/v) solution of
acetonitrile and 100 mм ammonium
bicarbonate and dried under vacuum.
Proteins contained in gel pieces were
reduced y using 10 mм Tris ( car oxyethyl) phosphine hydrochloride in
0.1 м ammonium icar onate at 56 C for 45
min and then alkylated ith 55 mм
iodoacetamide in 0.1 м ammonium
bicarbonate at room temperature for 30 min.
the alkylated sample was washed as
described above, dried, and soaked in
sequencing- grade trypsin (500 ng) on ice
for 45 min. Then, the gel pieces were
immersed in 100 μl of 500 mм ammonium
icar onate at 7 C for 14- 18 h. Resulting
peptides were extracted sequentially for 20
min ith 45 acetonitrile in 0 mм
ammonium bicarbonate, 45% acetonitrile in
0.5% trifluoroacetic acid, and 75%
acetonitrile in 0.25% trifluoroacetic acid

with agitation. Pooled peptide extracts were
evaporated under vacuum. Digested peptides
were dissolved in Solvent A (5% acetonitrile
and 0.1% formic acid in H2O) and loaded
onto fused silica capillary columns
containing 8 cm of 5- μm particle size Aqua
C18 reverse- phase column material. The
column was placed in- line with an Agilent
HP 1100 quaternary LC pump and a splitter
system was used to achieve a flow rate of
250 nl/ min, with a 90- min gradient of
Solvent A and Solvent B (80% acetonitrile
and 0.1% formic acid in H2O). Eluted
peptides were directly electrosprayed into an
LCQ Deca XP Plus mass spectrometer
(ThermoFinnigan, Palo Alto, CA) by
applying 2.3 kV of DC voltage. A datadependent scan consisting of one full mass
scan (400- 1400 m/z) and three datadependent tandem mass scans were used to
generate tandem mass spectra of eluted
peptides. Normalized collision energy of
35% was used throughout the data
acquisition. Tandem mass spectra were
searched against an in- house protein data
base using TurboSequest and
phosphorylation modification (+ 80 on Ser,
Thr, and Tyr) was considered in the
differential modification search. Bioworks
version 3.1 was used to filter the search
results and the following Xcorr values were
applied to different charge states of peptides:
1.8 for singly charged peptides, 2.2 for
doubly charged peptides, and 3.2 for triply
charged peptides. Tandem mass spectra for
phosphorylated peptides were generated
using Xcalibur version 3.1 and manual
assignment of fragment ions was performed
to confirm the search results.

RESULTS
Lipid Selectivity of hSK1Conflicting results have been reported on the
lipid selectivity of SK. An earlier report
showed that phosphatidylserine (PS) is the
most effective activator of SK (26), whereas
a recent report suggested that SK1 has the
high affinity for phosphatidic acid (PA)
(27). To resolve this controversy and
determine the exact role of these lipids in
membrane targeting of SK1, we first
measured the in vitro membrane binding
parameters of recombinant hSK1 using
vesicles with various compositions by
means of the SPR analysis. The SPR
analysis of membrane- protein interactions
offers an advantage over other methods in
that membrane association (ka) and
dissociation (kd) rate constants can be
directly determined (21, 28- 30). We have
recently shown that nonspecific electrostatic
interactions driven by ionic residues mainly
effect ka, whereas short- range specific
interactions and hydrophobic interactions,
which result from the membrane penetration
of hydrophobic residues, largely influence kd
(21, 20, 31). Fig. 1 shows representative
sensorgrams for hSK1- vesicle binding from
which ka, kd, and Kd were determined.
hSK1 did not bind to Zwitterionic
POPC or POPE vesicles with protein
concentrations up to 5μм, ut sho ed higher
affinity for vesicles containing anionic
phospholipids. Because the inner plasma
membrane of mammalian cells contains
about 30 mol % of total anionic lipids, we
first determined Kd values for mixed vesicles
containing 30 mol % of various anionic
lipids (i.e. POPC/POPX (70:30)). The
comparison of Kd values (TABLE ONE)

shows that hSK1 has definite selectivity for
PS over other anionic phospholipids.
Although hSK1 bound to PA slightly better
than phosphatidylglycerol and
phosphatidylinositol, it still showed 5- fold
higher affinity for PS than for PA. When
lower concentrations of anionic lipids were
employed (e.g. POPC/POPX = 80:20 or 85:
15), essentially the same PS selectivity was
observed (data not shown).

Also, the PS selectivity remained unchanged
when pH of the binding solution was varied
from 7.4 to 8.1 (i.e. [Kd for POPC/POPA
(7:3)]/ [Kd for POPC/ POPS (7:3)] = 4.7 at

pH 8.1), precluding the possibility that
selectivity of hSK1 for PS over PA affinity
reflects incomplete ionization of PA under
our experimental conditions. Higher pH
could not be used because of a loss of hSK1
activity at pH > 8.3. Furthermore, the
addition (up to 3 mol %) of SPH, PMA,
diacylglycerol, or any phosphoinositides to
POPC/ POPS (70:30) vesicles had little
effect on the affinity of hSK1 (data not
shown). Higher affinity (i.e. Kd) of hSK1 for
PS derives mainly from smaller kd, which
suggests that the PS head group specifically
interacts with hSK1 and may also induce
membrane penetration of hSK1 to slow the
membrane dissociation.
It has been shown for many
membrane- targeting domains and their host
proteins that binding of their cognate lipid
ligand leads to membrane penetration of the
protein (31- 34). To see if PS specifically
induces the membrane penetration of hSK1,
we measured the penetration of hSK1 into
various lipid monolayers at the air- water
interface.

The phospholipid monolayer was spread at a
constant area and the change in surface
pressure (Δπ) as monitored after injection
of protein into the subphase. In general, Δπ
is inversely proportional to πo of the lipid
monolayer and an extrapolation of Δπ

versus πo plot yields the critical surface
pressure (πc), which specifies the upper limit
of πo of a monolayer that a protein can
penetrate into (24, 35). Because the surface
pressure of cell membranes has been
estimated to be in the range of 30- 35 dyne/
cm (36- 8), the πc value for a protein that
penetrates cell membranes should be above
30 dyne/ cm. As shown in Fig. 2A, hSK1
showed weak penetration into the POPC,
POPC/ POPG (7:3), POPC/ POPI (7:3),
POPC/ POPA (7: ) monolayer ith πc < 26
dyne/ cm. However, hSK1 had stronger
penetration activity toward the POPC/ POPS
(7: ) monolayer ith πc ≥ 0 dyne/ cm. This
suggests that PS specifically induces the
membrane penetration of hSK1 and thus
allows its favorable hydrophobic interaction
with cell membranes. It should be noted that
large unilamellar vesicles used in our SPR

measurements are known to have the surface
pressure above 30 dyne/ cm (36- 38). This
explains why hSK1 shows no affinity for
switterionic POPC or POPE vesicles and
weaker affinities for non- PS- containing
anionic vesicles through nonspecific
electrostatic interactions in the SPR
measurements.
Our recent studies have shown that
peripheral proteins with PS selectivity have
a high tendency to be localized at the
cytoplasmic face of the plasma membrane
(22, 39, 40), either in response to specific
signal or constitutively, because of high PS
content of this membrane. Thus, the reported
PMA- induced translocation of hSK1 to the
plasma membrane (17) might derive, at least
in part, from its preference for PS in the
plasma membrane. To test this notion, we
measured the binding of hSK1 to vesicles

the nuclear membrane, and early
endosomes, respectively (22). This approach

has been successfully used to determine the
origin of specific subcellular localization of
various cellular proteins (31).
As shown in TABLE TWO, hSK1 had
striking selectivity for the plasma membrane
mimetic over other cell membrane mimetics.
In particular, it showed almost 400- fold
higher affinity for the plasma membrane
mimetic than for the nuclear membrane
mimetic. It should be noted that this plasma
membrane selectivity is much more
dramatic than the PS selectivity determined
above because the plasma membrane is not
only rich in PS but also the most anionic
membrane in all cell membranes. This
exceptional selectivity of hSK1 for the
plasma membrane mimetic strongly suggests
the lipid head group selectivity be a main
force governing its specific subcellular
localization. This also implies that the
agonist- induced plasma membrane
translocation of this protein be regulated by
modulating the lipid- protein interactions.
whose lipid head group compositions mimic
those of the cytoplasmic plasma membrane,

Structural Determinants of PS
Selectivity and Cellular Membrane
Targeting and Activation- The structural
information on the stereospecific recognition
of the PS head group by its effector protein
is limited. IN the case of the C2 domain of
PKCα that was crystallized with a PS
molecule, the side chain of an Asn residue

directly interacts with the serine head
group of PS, whereas the side chain of a Thr
residue interacts with other polar moieties of
PS (41). To identify potential PS binding
residues in hSK1, we searched polar
residues capable of interacting with the PS
head group, i.e. Asn, Ser, or Thr, which are
conserved among SKs (Fig. 3). The search
identified at least eight highly conserved
residues, including, Thr54, Ser79, Asn89,
Ser112, Asn114, Ser119, Ser165, and Ser168. To
see if any of these residues are involved in
PS head group recognition, we mutated
them to Ala individually and measured the
effects on PS selectivity. For the sake of
simplicity, we determined the PS selectivity
of mutants by comparing their affinity for
POPC/ POPS (7:3) and POPC/ POPG (7:3)
vesicles. Interestingly, T54A and N89A
showed dramatically reduced PS selectivity
(TABLE ONE), whereas S168A (TABLE
ONE) and other mutants (data not shown)
either behaved like wild type or were not
functionally expressed, implying that Thr54
and/ or Asn89 might be specifically involved
in PS interaction. Interestingly, Asn89 is
located within the putative ATO- binding
region (between residue 82 and residue 103)
(Fig. 3) (42), which should be located near
the membrane- binding surface for hSK1 to
be able to phosphorylate the membraneimbedded substrate, SPH. Reduced PS
selectivity of T54A and N89A was not
because of deleterious structural changes
caused by mutations because these mutants
showed only slightly reduced affinity for
POPC/ POPG (7:3) vesicles (TABLE ONE).
Consistent with their reduced PS selectivity,
T54A and N89A also had much lower (i.e.
22- to 24- fold) selectivity for the plasma
membrane mimetic over the nuclear
membrane mimetic than the wild type (373fold; TABLE TWO). It should be noted that
despite their lack of PS selectivity T54A and
N89A still prefer the plasma membrane
mimetic to other cell membrane mimetics

because the highly anionic nature of the
plasma membrane mimetic allows favorable
nonspecific electrostatic interactions with
these proteins.
To determine whether these PSbinding residues are also important for the
enzymatic activity of hSK1, we performed
in vitro activity assays for wild type, T54A,
N89A, and S168A in the absence and
presence of lipid vesicles of various
compositions. When the activity was
measured in the absence of lipid vesicles,
wild type and all mutants had comparable
specific activities (Fig. 4), indicating the
mutations did not disrupt the structural
integrity of the active site of the enzyme.
When the activity was measured using SPH
incorporated into zwitterionic PC vesicles,
no increase in activity was observed for any
protein (Fig. 4). When anionic POPC/ POPA
(7:3) vesicles were used in the activity
assay, wild type and all mutants uniformly
showed about a 2.5- fold enhanced activity
(Fig. 4). In the presence of POPC/ POPS
(7:3) vesicles, however, wild type and
S168A showed significantly higher activity
than T54A and N89A (Fig. 4). Interestingly,
T54A and N89A showed similar activities in
the presence of POPC/ POPA (7:3) and
POPC/POPS (7:3) vesicles, indicating that
the PA activation is largely because of
nonspecific electrostatic binding to anionic
membranes, whereas the PS activation is a
specific process.
These data thus indicate that specific
PS binding of hSK1 mediated by Thr54 and
Asn89 is important not only for membrane
binding of hSK1 but also for the enzymatic
action of hSK1 on membrane- incorporated
SPH.

To see if Thr54 and Asn89 also play a
key role in the subcellular localization of
hSK1, we measured the cellular membrane
translocation of hSK1 and mutants in
HEK293 cells. The Western blotting
analysis using a hSK1- specific antibody
(17) indicated that all proteins were
expressed in comparable levels (data not
shown). The C- terminal EGFP- tagged
hSK1 transiently transfected into HEK293
cells was recruited to the plasma membrane
within 10 min in response to PMA
stimulation (Fig. 5A). In stark contrast,
EGFP- T54A (Fig. 5B) and EGFP- N89A
(Fig. 5D) showed no detectable translocation
under the same conditions. Unlike these
mutants, EGFP- S168A with wild type- like
membrane binding properties readily
translocated to the plasma membrane upon
PMA treatment (Fig. 5C).
We then measured the cellular
activity of these proteins by labeling the
aforementioned transfected HEK293 cells
with ᴅ- [erythro- 3H]SPH and monitoring
the release of the radioactive S1P into the
media. As shown in Fig. 6, PMA induced a
4- fold increase in S1P release over the
control for wild type and S168A, whereas
little to no increases in S1P release over the
controls were detected for T54A and N89A
with and without PMA. Collectively, these

results indicate that Thr54 and Asn89, located
in the putative membrane- binding surface
of hSK1, play an essential role in its PS head
group recognition, subcellular localization,
and cellular activity. This also supports the
notion that the subcellular localization of
hSK1 is governed in large part by the lipidprotein interactions.
Effect of Ser225 Phosphorylation on
the Membrane Targeting of hSK1- It has
been reported that Ser225 of SK1 is
phosphorylated by extracellular signalregulated kinase 1/2 in response to PMA or
tumor necrosis factor- α stimulation in
HEK293 cells, which leads to PM targeting
and activation of SK1 (18).

To investigate how Ser225
phosphorylation activates hSK1, we
prepared phosphorylation and
dephosphorylation- mimicking mutants,
S225E and S225A, and measured their
binding to cell membrane mimetics. As
summarized in TABLE TWO, the
membrane affinity of S225E was
comparable with that of wild type, implying
that a large population of hSK1 molecules
expressed in insect cells are phosphorylated
at Ser225. To test this notion, we determined
the phosphorylation of Ser225 in insect cellexpressed recombinant hSK1 by mass
analysis. Tandem mass spectrometry data of
tryptic peptide fragments containing Ser225
(Fig. 7) consistently showed that Ser225 was
phosphorylated in hSK1 expressed in insect
cells.

Although quantification is
impractical with the current mass
spectrometry analysis,
the relative height of phosphorylated and
non- phosphorylated.
Most important, S225E had about 10
times higher affinity (i.e. lower Kd) for the
plasma membrane mimetic than S225A,
establishing that Ser225 phosphorylation
greatly enhances the affinity of hSK1 for the
plasma membrane. Interestingly, the S225A
mutation lowered the membrane affinity
primarily by increasing kd, which is
reminiscent of the effect of the T54A and
N89A mutations. This implies that Ser225
phosphorylation may be somehow linked to
the PS- mediated membrane interactions of
Asn89 and Thr54.

This notion is supported by the finding that
S225A, like T54A and N89A, had
significantly reduced selectivity for the
plasma membrane mimetic over the nuclear
membrane mimetic than did S225E and wild
type (TABLE TWO).
Furthermore, in a monolayer
penetration assay using the POPC/ POPS
(7:3) monolayer, S225A, T54A, and N89A
all had significantly lower πc values than
S225E and wild type (Fig. 2B). In particular,
the penetration of S225A into the POPC/
POPS (7:3) monolayer was comparable with
the penetration of wild type hSK1 into nonPS containing monolayers (Fig. 2A). These
results suggest that Ser225 phosphorylation
may regulate the membrane targeting of
hSK1 by modulating the specific interaction
of Asn89 and Thr54 with the PS- containing
membrane.
We also measured the cellular
membrane targeting of C- terminal EGFPtagged hSK1, S225A, and S225E transiently
transfected into HEK293 cells. When
transfected cells were stimulated with PMA,
S225E translocated to the plasma membrane
as well as wild type (Fig. 5E), whereas
S225A translocated significantly more
slowly than wild type (Fig. 5F), in
accordance with its lower in vitro membrane
affinity. Collectively, these results indicate
that Ser225 phosphorylation regulates the
membrane targeting of hSK1 both in vitro
and in the cell, presumably by modulating
the interactions of Asn89 and Thr54 with the
membrane.
DISCUSSION
This study systematically
investigates the mechanism by which
subcellular localization and activation of
SK1 is regulated. Because the main
physiologic substrate of SK1 is the
membrane lipid SPH and SK1 is normally a
cytosolic protein, the activation of SK1

should involve its membrane recruitment
either through protein- lipid and/ or proteinprotein interactions. Although some proteins
have been reported to interact with SK1 (19,
20), the physiological relevance of proteinmediated subcellular localization of SK1 has
not been established. The present study
provides new evidence supporting the notion
that the lipid- protein interactions play a
major role in regulation of membrane
translocation and activation of SK1: i.e.
specific plasma membrane targeting SK1
derives from its selectivity for the PS head
group and the phosphorylation of Ser225
activates SK1 by enhancing its plasma
membrane affinity.
Although direct structural
information is not available for any SK at
present, the sequence comparison of SKs
from different species allowed us to identify
the residues essential for the PS specificity
of hSK1. Our in vitro vesicle binding
measurements of wild type and mutants
indicate that hSK1 specifically interacts with
PS via the side chains of Thr54 and Asn89.
These data, in conjunction with the fact that
the cellular concentration of OS is much
higher than PA, strongly dispute the notion
that SK1 might act as a specific PA effector
in the cell (27). The PS specificity of hSK1
would allow the protein to translocate
selectivity to the cytoplasmic leaflet of the
plasma membrane that is rich in PS. The
notion is supported by exceptional
selectivity of hSK1 for the plasma
membrane mimetic over other cell
membrane mimetics, which is dramatically
reduced by the T54A or N89A mutations.
Thus, along with the C2 domains of protein
kinase Cα and phospholipase Cδ1 (22, 39),
hSK1 belongs to an expanding group of
cellular signaling proteins that are targeted
to the plasma membrane from the cytosol
because of their selectivity for the PS head
group.

In the case of PKCα, PS has been reported
to specifically induce the conformational
change and membrane penetration of the
protein (43, 44). This PS- mediated process
not only enhances the membrane affinity of
PKCα but also activates the protein by
opening the active site of the enzyme. It is
difficult to directly compare the activation
mechanisms of PKCα and SK1 because
PKCα activation also involves
diacylglycerol. A main similarity is,
however, that PS enhances the membrane
penetration of both proteins, thereby
increasing their residence time (i.e. smaller
kd) and affinity (i.e. smaller Kd) for densely
packed lipid bilayers including cell
membranes. Because little is known about
the enzyme activation mechanism of SK1, it
is unclear whether the PS- induced
membrane penetration of SK1 would simply
enhance the membrane affinity or also cause
the enzyme activation at the membrane
surface. More studies are needed to address
this important issue.
The mechanism by which
phosphorylation regulates the membrane
targeting and activation of SK has not been
elucidated. It has been reported that
phosphorylation of Ser225 activates SK1
presumably by promoting its plasma
membrane targeting (18). Our results

indicate that phosphorylation of
Ser225 not only enhances the overall
membrane binding affinity of hSK1 but also
increases its selectivity for the plasma
membrane. This raises an interesting
possibility that phosphorylation of Ser225
modulates the interaction of the two PSbinding residues, Asn89 and Thr54, with the
membrane. This notion is supported by our
monolayer penetration measurements
showing that Ser225 phosphorylation
enhances the penetration of hSK1 into the
PS- containing monolayer. The relative
location of Ser225 and the PS- binding
residues in hSK1 are not known at present.
If they are located in proximity, Ser225
phosphorylation would regulate the
membrane interaction of these residues
through short- range electrostatic
interactions. If, on the other hand, Ser225is
remote from Asn89 and Thr54, Ser225
phosphorylation would regulate the
membrane binding through a long- range
conformational change, as seen with other
membrane- binding proteins, such as
cytosolic phospholipase A2α (45).
On the basis of these results and
other available data, we propose a
mechanism by which the membrane
targeting and activation of SK1 is regulated
in the cell (Fig. 8). When Ser225 is not
phosphorylated, SK1 cannot fully exert its

PS- specific binding and therefore only
weakly interacts with the anionic plasma
membrane through nonspecific electrostatic
interactions Phosphorylation of Ser225 allows
Thr54 and Asn89 to specifically interact with
PS in the plasma membrane, which induces
partial membrane penetration of SK1 and
greatly enhances the membrane affinity of
SK1. Slower membrane dissociation and
elongated membrane residence of SK1
caused by specific PS binding will allow
SK1 to laterally diffuse in the plane of
membrane, finding its substrate SPH, to
catalyze the phosphorylation in a processive
manner. Our hypothetical model is based on
the premise that the activation of SK1 is
regulated mainly at the stage of its
membrane binding: i.e. cell stimuli activate
SK1 mainly by enhancing its membrane
affinity. This notion is consistent with the
good quantitative correlation between the in
vitro affinities of hSK1 and mutants for the
plasma membrane mimetic and their cellular
properties. Such a correlation would not be
expected if, for instance, Ser225
phosphorylation mediated protein- protein
interactions. It should be noted that this
model is still largely hypothetical and
further structural and functional studies are
necessary to test the model. For instance,
there are no possibilities that some cellular
agonists of SK1 and other types of SK1
phosphorylation may mediate proteinprotein interactions. Nonetheless, this study
provides new insights into the mechanism
by which the membrane recruitment of this
important protein is regulated and also lays
the groundwork for more systematic
mechanistic and functional studies.
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